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Abstract
For influenza virus hemagglutinin, an N-cap structure, created at low pH, interacts with membrane-proximal residues (173–178),
bringing fusion peptides and membrane-spanning domains close together. Mutational analysis was used to define the role of these
interactions in membrane fusion. For all N-cap mutants, both lipid and aqueous dye spread was greatly reduced. Mutation at residues that
interact with the N-cap did not reduce levels of fusion, except for substitutions made at residue I173. For N-cap and I173 mutants, the
addition of chlorpromazine greatly promoted transfer of aqueous dye. Electrical capacitance measurements confirmed that fusion pores
usually did not form for the I173 mutants. Thus, neither N-cap formation nor interactions with segment 173–178 are needed for hemifusion,
but are required for reliable formation and enlargement of the fusion pore. It is proposed that binding of I173 into a deep hydrophobic cavity
within the coiled-coil promotes the transition from hemifusion to fusion.
© 2003 Elsevier Inc. All rights reserved.
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Introduction
Fusion of a viral envelope with a cell membrane is the
event that allows the transfer of a viral genome into the
cytosol of an infected cell. For influenza virus, the protein in
the envelope responsible for membrane fusion is hemagglu-
tinin (HA). HA is a homotrimer, each monomer consisting
of two subunits, HA1 and HA2. HA1 binds influenza to
cells, and HA2 is the subunit that induces membrane fusion.
For viral fusion proteins in general, the fusion proteins are
trimers and the majority of the protein lies outside the virus
and is known as the ectodomain. Each monomer of the
subunit responsible for fusion contains a “fusion peptide”
and a single transmembrane domain (TMD). Fusion pep-
tides are stretches of about 20 nonpolar amino acid residues
that insert into the target membrane during fusion (Durrer et
al., 1996; Hernandez et al., 1996; Stegmann et al., 1991).
More is known about HA’s conformational changes dur-
ing fusion than is known for any other fusion protein.
Influenza virus is internalized into cells by endocytosis, and
the low pH of the endosome triggers conformational
changes in HA that culminate in fusion. The structure of the
ectodomain of HA has been crystallographically determined
in its uncleaved form (Chen et al., 1998), its native cleaved
neutral-pH form (Wilson et al., 1981 Skehel, and Wiley,
1981), as well as its low-pH, postfusion form (Bullough et
al., 1994; Chen et al., 1999). The final, postfusion form of
ectodomains (or peptide fragments of them) for many pro-
teins from diverse viral families have also been determined.
Thus we know that the ectodomains of fusion proteins from
many viruses—including HA of influenza, HIV-1 (Chan et
al., 1997; Weissenhorn et al., 1997), simian immunodefi-
ciency virus (Caffrey et al., 1998), human T-cell leukemia
virus (Kobe et al., 1999), Moloney murine leukemia virus
(Fass et al., 1996), Ebola virus (Eckert et al., 1999; Weis-
senhorn et al., 1998), and the paramyxoviruses SV5 (Baker
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et al., 1999) and respiratory syncytia virus (Zhao et al.,
2000)—exhibit great structural similarity. Typically, there
is a central core of a triple-stranded coiled-coil formed from
N-terminal -helices. This creates three grooves into which
the three C-terminal -helices pack antiparallel to the cen-
tral core. For many of the proteins, the C-terminal segments
fit as -helices into the grooves of the central triple-stranded
coiled-coil, yielding the rod-like structure of a six-helix
bundle. For proteins that have only short stretches between
both the TMD and C-terminal helices, and between the
fusion peptide and the coiled-coil, formation of the six-helix
bundle alone brings the fusion peptides and TMDs into
close proximity as a direct consequence of the antiparallel
arrangement of the N- and C-terminal -helices (Baker et
al., Skehel and Wiley, 2000; Eckert and Kim, 2001). But
HA2 has a lengthy stretch of amino acids between the short
C-terminal helices of the six-helix bundle and the TMDs.
The crystal structure shows, however, that the fusion pep-
tides and TMDs should still come into close proximity. The
lengthy stretch of amino acids runs as an extended chain
along the grooves of the coiled-coil, and residues toward the
C-termini of this extended conformation bond with N-ter-
minal residues that end the -helices of the central coiled-
coil core (Chen et al., 1999). The structure formed by the
residues at the N-terminus of the -helices is known as an
“N-cap.”
Clearly, the absence of successive residues (as part of the
helix) at the ends of an -helix prevents the main-chain
carbonyl oxygens and amide hydrogens from forming as
many hydrogen bonds with each other as those internal to
the helix. As a result, for many -helices the side chains of
the end residues loop back to bond to adjacent residues of
the helix and when they do, the -helix is terminated in a
way that prevents its unraveling (Presta and Rose, 1988;
Richardson and Richardson, 1988). In the case of HA at low
pH, residues at the N-terminus of the coiled-coil (explicitly,
residues 34–37) interact not only with adjacent residues of
their own -helices, but also with residues of the other two
helices. Residues 34–37 thereby form an N-cap structure
that both terminates the individual -helices and serves to
tie the three helices of the coiled-coil together. The fusion
peptide of HA is at the N-terminus (residues 1 through 20)
and is therefore close to the N-cap structure. The residues of
the C-terminal chain that interact (residues 173–178, which
we refer to as the N-cap interacting residues or “NCI resi-
dues”) with residues of the N-cap are similarly close to the
TMD (residues 186–212). Consequently, the fusion pep-
tides and the TMDs must be in close proximity and might
even intermingle in the final HA structure. When the ex-
tended chains are within the grooves and the NCI residues
interact with the N-cap, we refer to the structure as a
“trimeric hairpin.”
Proximity of the fusion peptides and TMDs is generally
thought to be critical to viral fusion (Cohen, 2002; Ferrer et
al., 1999). For intracellular fusion, proximity of TMDs of
SNAREs, comprising tetrameric coiled-coils, inserted in
opposite membranes is also thought to be essential for
fusion (McNew et al., 2000; Sutton et al., 1998). However,
it is not known where, in the multistep process of viral
membrane fusion, proximity of fusion peptides and TMDs
is achieved and if it is truly an important factor. Since
proximity between fusion peptides and TMDs of HA is
effected by interactions between very discrete regions—the
N-cap and residues 173–178 (Chen et al., 1999)—the ener-
gies of these interactions can be substantially reduced by
site-directed mutagenesis. Through this approach, we show
that neither the N-cap nor the NCI residues are needed to
achieve hemifusion (the merger of contacting, proximal
monolayer leaflets of membranes). But the N-cap and a
particular NCI residue, I173, promote fusion pore formation
and enlargement. We propose that it is the interaction be-
tween the N-cap and I173 that promotes the steps down-
stream of hemifusion.
Results
Selecting sites for specific mutations
For HA2 at low pH, residues that are part of and adjacent
to the N-cap interact extensively with residues 173–178
(Chen et al., 1999). We aligned sequences of HA from 14
subtypes of influenza virus and found that Ala35, Ala36,
and Asp37 are conserved, as noted previously (Chen et al.,
1999), but that residue 34 (Gln for X:31 HA used in this
study) is not. Also conserved are Ser40 and Thr41, which
are part of the -helices terminated by the N-cap. Alignment
also shows that Ile173, Val176, and Leu178 (residues that
interact with the N-cap) are conserved with exception of
isolated variations. The precise structures of the N-cap and
the NCI region, or their interactions, are presumed to be
essential in fusion (Chen et al., 1999); this is supported by
the high degree of conservation in a highly mutating protein.
We introduced either single or double mutations at residues
35–37, choosing amino acids known to statistically disfavor
formation of N-caps (Richardson and Richardson, 1988).
We also mutated the NCI residues that are hydrophobic and
conserved (residues 173, 176, and 178) to residues with
polar side chains so as to hinder interactions with the N-cap.
We initially made the mutations I173E, V176E, and L178Q
and found that only I173E had a dramatic effect on fusion.
We therefore made several other mutations at position 173.
We also deleted the region 173–178.
Cell surface expression, cleavage, and conformational
changes in mutant HA
Wild-type HA (wt HA) and each mutant were expressed
in cells by transfection. In order to compare the ability of a
mutant HA to induce fusion with the ability of wt HA, it was
necessary to express them with comparable densities. This
was done by manipulating the amount of DNA used and,
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when necessary, elevating expression levels of a mutant by
adding sodium butyrate to the cell culture medium 18 h
prior to use (Danieli et al., 1996). Cell surface expression
levels (Fig. 1) were measured by flow cytometry (FACS)
(see Materials and methods) or alternatively were assessed
by a cell-ELISA assay (data not shown). FACS and ELISA
measurements yielded the same comparative expression
levels between mutants. For all the mutants, both those
within the N-cap itself (Fig. 1A) and the NCI residues (Fig.
1B), conditions were adjusted to yield expression levels
similar to that of wt HA. Because mutations at I173 were
deleterious to fusion, we also expressed I173E at three times
the level of wt HA and observed improved fusion, but the
extent of fusion was still much less than that for wt HA (see
Fig. 6).
HA was expressed on the 293T cell surfaces in its un-
cleaved HA0 form. Treating the cells with small amounts of
trypsin properly cleaved wt HA0 at a single site (Fig. 2). If
a mutated HA misfolds, sites susceptible to cleavage by
trypsin tend to become exposed, and this provides a means
to test for proper folding. In order to determine whether HA
on the surface of the cells had been properly cleaved by
trypsin, it was necessary to exclude from analysis any HA
located in intracellular pools, such as Golgi. We accom-
plished this by biotinylating surface proteins (Qiao et al.,
1999). Cells were then treated with trypsin, HA was immu-
noprecipitated by an anti-HA1 antibody, and the immune
complexes were subject to Western blot analysis. By bind-
ing strepavidin–HRP, the biotinylated HA0 as well as the
cleaved HA1 subunit were identified. Because the anti-HA1
antibody did not bind to HA2, HA2 is never present in the
gel. Wild-type and all point mutants (except for T41K and
T41E) were properly cleaved by trypsin (Fig. 2), indicating
that they had folded properly. T41K and T41E were more
severely digested by trypsin, demonstrating some misfold-
ing. We therefore do not further pursue the consequences of
mutation at residue 41 on fusion.
The deletion mutant 173–178 appeared to be properly
folded, although some surface HA0 was cleaved without
adding trypsin, showing that this mutant was more readily
cleaved by intracellular proteases than was wt HA. Thus,
either slight misfolding occurred or the absence of residues
173–178 facilitated exposure of the cleavage site during
intracellular transport. The fraction of the deletion mutant
that did reach the cell surface in its HA0 form was properly
cleaved by external trypsin.
We determined whether the mutants underwent proper
conformational changes at low pH, using an antibody
(CHA-1) that recognizes an epitope that is normally only
exposed at low pH (White and Wilson, 1987). We measured
antibody binding by cell-ELISA and found that all the point
mutants underwent pH-dependent conformational changes
similar to that of wt HA (Fig. 3). For mutations within the
N-cap, the pH dependences of these changes were some-
what less steep than that of wt HA (Fig. 3A). Mutations at
I173 did not alter at all the pH dependence for conforma-
tional changes (Fig. 3B). Having established that mutants
were expressed well, that most were properly folded, and
that they underwent appropriate low-pH conformational
changes, we determined their ability to induce fusion. In the
cases in which fusion was impaired, we determined how far
in the process fusion had proceeded.
Fig. 2. SDS–PAGE of HA cleaved by trypsin. (A) N-cap mutants. (B)
Mutations at I173 and deletion of the NCI residues; see Materials and
methods for details. Separate gels were cut and pasted for visual display.
Fig. 1. Cell surface expression of wt HA and mutants. (A) N-cap mutants.
(B) N-cap interacting residue (NCI residue) mutants. In all cases, mutants
were expressed on cell surfaces at comparable or greater levels, as deter-
mined by FACS analysis. Error bars are SEM from at least three indepen-
dent experiments.
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Fusion activity
Fusion between HA-expressing cells and RBCs was trig-
gered by lowering pH. Fig. 4 compares the behavior of wt
HA and two mutants, one within the N-cap, D37V, and one
NCI residue mutant, I173P. For wt HA, both R18 and CF
transferred after lowering of pH, showing that full fusion
resulted. However, neither appreciable lipid mixing nor
content mixing occurred for either mutant. It is thought that
hemifusion is an intermediate stage of fusion (Cohen,
2002), and at this stage lipid movement is restricted (Cher-
nomordik et al., 1998). The restriction of lipid dye move-
ment may be due to the high density of HA at the site of
hemifusion, which would occlude the passage of lipid
(Chernomordik et al., 1998). The existence of this hemifu-
sion stage is inferred if the addition of chlorpromazine
(CPZ)—a membrane-permeable weak base that preferen-
tially partitions into inner leaflets of cell membranes—leads
to full fusion (Chernomordik et al., 1998; Melikyan et al.,
1999, 2000a). (When hemifusion diaphragms are known to
exist, CPZ disrupts them (Melikyan et al., 1997).) For both
mutants, the addition of CPZ induced lipid and aqueous dye
spread. Content mixing after the addition of CPZ indicates
that, for these mutants, fusion had become arrested at a state
of hemifusion in which lipid movement was restricted. As a
consequence of mutation, the process did not continue on to
full fusion.
These procedures of testing for hemifusion and/or fusion
were extended to include all the mutants that expressed,
folded correctly, and underwent appropriate low pH-depen-
dent conformational changes. The percentage of the HA-
expressing cells with bound RBCs that became stained by
R18 (Figs. 5 and 6, filled bars) and by CF (open bars) after
lowering of the pH is shown for these mutants. All the
mutations within the N-cap region were deleterious to both
lipid and aqueous dye spread (Fig. 5A); within the region
173–178, only mutations at position 173 were particularly
destructive (Fig. 6A). All of the N-cap mutants, except
A35E, exhibited less than 30% of the lipid-mixing activity
of wt HA and the level of content mixing was even more
reduced. After adding CPZ, content mixing comparable to
that of wt HA was observed for all the mutants (Fig. 5B). It
is particularly notable that all mutant HA-expressing cells
with a bound RBC that did not exhibit dye transfer after
lowering of pH did display contents mixing after the addi-
tion of CPZ. We conclude that the mutant HA cell and RBC
membranes were in a state of local hemifusion prior to the
addition of CPZ. For wt HA, this state of hemifusion transits
to full fusion.
Mutating the NCI residue 173 had a greater effect on
content mixing than did mutating residues of the N-cap
itself. The single mutants I173Y, I173P, and I173E exhib-
ited negligible content mixing (Fig. 6B). The point muta-
tions V176E and L178Q did not significantly affect fusion.
Thus, whereas mutation anywhere within the N-cap region
tended to inhibit fusion, mutation within the interacting
C-terminal region that reduced fusion was localized to res-
idue 173. The addition of CPZ augmented content mixing
for all the NCI residue mutants tested, usually to the max-
imum extent possible (Fig. 6B).
To determine whether mutants at I173 could support any
fusion, we focused on I173E, because this mutant yielded
the greatest evidence of some fusion activity. We expressed
I173E to three times the surface density of wt HA. Lipid dye
spread for the overexpressed mutant was comparable to that
of wt HA (Fig. 6A, third open bar). The extent of aqueous
dye spread was now significant, but was still only about
30% of wt HA. It is striking that point mutations at a single
residue, I173, could completely abolish aqueous dye spread.
But clearly, fusion could be restored, at least to some extent,
by expressing an I173 mutant at higher density. We did not
explore whether fusion continued to increase with expres-
sion levels to the point that eventually all cells would be
able to fuse.
Even when an aqueous dye does not transfer, it remains
possible that a pore too small to allow dye spread has
formed. We used the patch clamp technique to perform
electrical capacitance measurements to check for this pos-
sibility, as capacitance measurements present the most sen-
sitive assay available to detect fusion pores. In 4 of 17
experiments using I173E expressed at the same density as
Fig. 3. The pH dependence of conformational changes in HA and mutants
is shown for (A) N-cap mutants (wt HA, filled circles; A35E, open
triangles; A35E-A36T, filled triangles; D37V, open diamonds) and (B)
mutations at residue I173 (wt HA, filled circles; I173E, open inverted
triangles; I173P, open squares; I173Y, filled squares). Each curve was
generated from at least three experiments.
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that in wt HA, we observed a small pore that did not enlarge
and was too small to allow for the passage of dye (Fig. 7,
bottom trace). In the remaining 13 experiments, no pores
formed (middle trace). In contrast, for wt HA, a pore almost
always formed and enlarged (top trace). Taken together, our
results strongly indicate that the N-cap is critical to fusion
and that this structure must properly interact with I173 for
the transition from hemifusion to full fusion.
Discussion
The trimeric hairpin of HA is analogous to the six-helix
bundle of other fusion proteins
Our data show that the N-cap, and its ability to interact
with residue I173, is critical for ensuring the transition from
hemifusion to fusion. The data also indicate, based on CPZ
sensitivity, that the stages up to and including hemifusion
occur without the participation of the N-cap or its interac-
tions with NCI residues. The blocking of fusion caused by
mutation at I173 could be partially overcome by overex-
pressing the mutant. It is often the case that for an inhibitory
effect on fusion to be observed, suboptimal fusion condi-
tions must be employed: conditions that promote fusion can
generally be made so optimal that the inhibitory effect can
be overcome. For instance, incorporation of lysophosphati-
dylcholine into outer monolayer leaflets of membranes in-
hibits hemifusion and thereby blocks fusion. But suboptimal
conditions are generally needed in order to clearly discern
the inhibition (Chernomordik et al., 1998). It is thus not
surprising that very high expression levels of a mutant can
obscure the fact that the site of mutation is in fact critical.
Fusion peptides insert into target membranes at low pH
(Durrer et al., 1996) and TMDs span the HA-expressing
membrane. Based on crystal structures of fusion proteins in
their postfusion form, these two membrane-spanning do-
mains should come close to each other and, in so doing,
would bring the two membranes into apposition (Eckert and
Kim, 2001; Skehel and Wiley, 2000). We have hypothe-
sized that bringing together the TMDs and fusion peptides
not only places the membranes in close apposition, but it is
Fig. 4. Images for the spread of membrane (R18) and aqueous (CF) dye from RBCs to HA-expressing cells for wt HA, D37V, and I173P. After low pH,
both dyes spread well for wt HA, but remained confined for both mutants (left columns). After addition of 0.5 mM CPZ for 1 min to solution, dyes spread
for both mutants (right columns). The dull appearance of R18 is due to its quenching by CPZ (31).
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also the event that disrupts the hemifusion diaphragm to
cause pore formation. (Markosyan et al., 2000; Melikyan et
al., 1999, 1995). For several fusion proteins, such as HIV-1
Env, formation of the six-helix bundle forces the TMDs and
fusion peptides into proximity. This is not the case for HA,
because there is a long, extended chain between the outer
helices of the six-helix bundle and the TMDs; the trimeric
hairpin of HA is the structure whose formation brings the
two membrane-inserted domains into proximity. Therefore,
in terms of function, the trimeric hairpin of HA is analogous
to the six-helix bundle of HIV-1 Env. For HIV-1 and SV5
fusion proteins, the six-helix bundle does not form until
after membrane merging has occurred (Melikyan et al.,
2000b; Markosyan, 2003; Russell et al., 2001). From the
present study we can similarly conclude that the trimeric
hairpin of HA does not form until after the membrane
merger. But because the six-helix bundle of HA is physi-
cally far from the TMDs, it remains possible that the bundle
forms prior to hemifusion (as illustrated in Fig. 8).
The structural alterations caused by mutation were local
Our mutations inhibited fusion through local alterations
of HA, not through any global deleterious effects: the mu-
tants were expressed well on cell surfaces, were properly
cleaved into HA1–HA2 subunits, and underwent low pH-
induced conformational changes. Every point mutation we
made in the N-cap (that was cell surface expressed) reduced
fusion; for cells that did not fuse, the fusion process was
always arrested at the same point: at a CPZ-sensitive state.
If mutations within the N-cap caused different, scattered
conformational changes throughout HA, one would expect
that fusion would become arrested at different points, de-
pending on the precise mutation. But the process was con-
sistently stopped at a CPZ-sensitive state, regardless of the
precise mutation, which supports our conclusion that the
N-cap participates in the fusion process only after hemifu-
sion has been achieved.
The sequence of intermediate states of membrane fusion
agrees with the expected sequence of HA structural
changes
At neutral pH, the triple-stranded coiled-coil of HA2 is
not terminated by an N-cap. The three “A”-helices, one
from each monomer of HA, have not yet folded into a
Fig. 6. Extents of fusion for NCI residue mutants. (A) R18 (open bars) and
CF (filled bars) transfers were most affected when residue I173 was
mutated. Expressing I173E at three times the surface concentration of wt
HA (I173E(3x)) partially restored fusion activity. (B) After addition of
CPZ, dye transfer was substantial for all mutants, even when all NCI
residues were mutated to alanine (I173–6A) or deleted altogether (173–
178). Error bars are SEM for at least three experiments.
Fig. 5. Extents of fusion for N-cap mutants. (A) R18 (open bars) and CF
(filled bars) transfers were less for all mutants than for wt HA. (B) After
addition of CPZ, dye transfer was comparable for mutants and wt HA.
Error bars are SEM for at least four experiments.
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coiled-coil (Fig. 8). For the A-helices to become part of the
coiled-coil, they must come together. This requires that each
B-loop reconfigure from its disordered arrangement at neu-
tral pH to an -helix at low pH that becomes part of the
extended coiled-coil. It is only after the A-helices have
become part of the coiled-coil that the N-cap can form to tie
them together. Therefore, one would expect that when N-
cap formation is blocked or when its interactions with NCI
residues are reduced, fusion proceeds further than when
B-loop conversion is hindered. Mutations have been made
that prevent B-loop conversion, and they abolish both fu-
sion and the creation of CPZ-sensitive states (Gruenke et al.,
2002; Qiao et al., 1998). That is, the formation of the
extended coiled-coil is necessary for hemifusion to occur.
We have found that mutations of the N-cap allow CPZ-
sensitive states to form and that mutation of NCI residues
allowed fusion to occur—except for mutation of I173,
which allowed fusion to proceed only up to a CPZ-sensitive
state. This is in accord with the order that conformational
changes of HA are expected to occur.
Residue I173 is critical for the formation and growth of
fusion pores
Mutation in the 173–178 region did not reduce fusion,
with the exception of one location. It is striking that muta-
tion at this residue, I173, could be so critical to the fusion
process. All mutations we made at residue I173 reduced
fusion, and in all cases fusion advanced up to a CPZ-
sensitive state, but generally no further. Even when a small
fusion pore was detected by electrical measurements, it
closed or did not enlarge.
Why might I173 be so critical? Based on structure, we
suggest that it is critical not only because it interacts with
the N-cap (as other NCI residues also do), but also because
it binds into a hydrophobic pocket, immediately adjacent to
the N-cap, of the extended coiled-coil. Previous research
has demonstrated that, for HIV-1 Env, the insertion of
C-terminal residues into the cavity of a coiled-coil to make
hydrophobic contacts is essential for fusion (Chan et al.,
1998). For HA at low pH, there are nonpolar contacts
between I173 and the N-cap. But the side chain of each I173
also fits into a hydrophobic pocket, created by T41, Q42,
and F45, within each groove of the coiled-coil; hydrogen
bonds between I173 and Q42 may help guide each I173 side
chain into its respective pocket (Fig. 9). I173 is unique
among the NCI residues in its ability to fit into a hydropho-
bic cavity. Of the conserved NCI residues, V176 and L178
also interact with the N-cap, but they are positioned beyond
the coiled-coil and cannot pack into a groove. The N-cap
appears to form a hydrophobic wall at the end of the pocket,
extending the hydrophobic surface beyond the pocket. In
this way, the N-cap shields the pocket from water, and this
may facilitate the hydrophobic binding of I173. It is possible
that the process occurs in the reverse order: I173 once
bound into the pocket of the coiled-coil might serve as a
nucleating center for N-cap formation. Alternatively, N-cap
formation and I173 binding may be a cooperative process,
occurring either sequentially or simultaneously. It may even
be that the pocket cannot form independently with its hy-
drophobic surface exposed to water and that, in fact, it
forms around I173. The absence of I173 would thereby
destabilize the coiled-coil in the vicinity of the unformed
pocket.
The structural importance of the N-cap can be appreci-
ated when one compares the crystal structure of the frag-
ment (EHA2, residues 23–185) that revealed the N-cap
(Chen et al., 1999) to the crystal structure as originally
determined, the low-pH fragment (TBHA2, residues 38–
175) that does not contain the N-cap (Bullough et al., 1994).
In the absence of the N-cap, the extended C-terminal seg-
ments are not packed into the grooves, and the stretch of
residues 162–175 is not structured; without the N-cap, it is
not apparent that the fusion peptides and TMDs would come
close to each other. The more complete, more recent crystal
structure (Chen et al., 1999) demonstrates that packing of
the C-terminal segments into the grooves of the coiled-coil
requires the existence of the N-cap and binding of I173.
Based on the crystal structure, this packing seems to be
highly dependent upon hydrophobic binding at a few dis-
crete sites, rather than upon binding along the entire chain;
I173 binds to one of these sites and the next critical location
appears to fall at the Y162 binding site.
There are two HA2 trimers in the crystal, and segment
173–178 is disordered in five of the six monomers. The
segment 173–178 of the sixth monomer has more hydrogen
bonds, conferring greater order and appears to form a
-sheet. The actual conformation of the 173–178 segment
may therefore fluctuate. The ability of the N-cap and I173
Fig. 7. Electrical measurements of fusion pores. (Top trace). Pores were
observed in 7 of 8 experiments for wt HA and these pores always enlarged
(Top trace). Pores were generally not induced by 1173E (middle trace), and
when they were (in 4 of 17 experiments), they tended to close and never
enlarge (bottom trace).
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interactions to promote pore formation may be aided by free
energy released by a favorable conformational transition of
the 173–178 segment.
The TMD and fusion peptides must interact for fusion
pore formation to occur
GPI-anchored ectodomains of HA have been molecu-
larly engineered (Kemble et al., 1993) that contain residue
I173. GPI-HA exhibits lipid dye spread at low pH (Kemble
et al., 1994; Melikyan et al., 1995), with pore formation
much more difficult to produce than for wt HA, and any
pores that do form do not enlarge (Frolov, 2000; Markosyan
et al., 2000). This is consistent with our central hypothesis
that reliable pore formation and enlargement requires that
the TMDs and fusion peptides approach each other subse-
quent to hemifusion.
A mutation within the TMD of an H2 subtype of HA has
also been shown to induce a CPZ-sensitive state, but not
pore formation (Melikyan et al., 2000a). This observation
supports the notion that cooperative actions between TMDs
and fusion peptides are necessary to induce pore formation
but are irrelevant for hemifusion to occur. In contrast, an
analogous mutation within the TMD of an H3 subtype
(X:31, the same strain used in the present study) did not
have an affect on fusion (Armstrong et al., 2000). But low
pH causes a much larger fraction of the H3 than the H2
Fig. 8. Model of HA-induced fusion. The HA2 subunit is shown in schema-
tized form; HA1 is omitted for visual clarity. As is known from crystallogra-
phy (Bullough et al., 1994; Chen et al., 1999), the C helix (dark blue) and the
D helix (light blue) of each monomer form a continuous -helix in the native
state (top). These helices form the central triple-stranded coiled-coil. Helix A
(pink) is antiparallel to this coiled-coil and is connected by the B-loop (purple).
After lowering of the pH (middle), the B-loop becomes an -helix. As a result
A, B, and C helices become one continuous -helix that forms an extended
coiled-coil. This allows the fusion peptide (bold black) to insert into the target
membrane. Residues in the middle of the continuous C and D helices become
random-coil and the D-helices pack antiparallel against the C-helices to form
a six-helix bundle. Although this is not adequate to bring fusion peptides and
TMDs (gray) toward each other, hemifusion nevertheless occurs. Only after
the N-cap (red ellipse with black border) and I173 (green asterisk in all three
panels) interact with each other do the TMDs and fusion peptides come into
close proximity, allowing pore formation and enlargement. The N-cap cannot
form until after the B-loop has become -helical; the six-helix bundle must
form for 1173 to interact with the N-cap. The crystallographic low-pH struc-
ture with N-cap is indicated by dashed box.
Fig. 9. Interactions of C-terminal residues with the central triple-stranded
coiled-coil. The coiled-coil is represented as an opaque molecular surface,
colored to denote the surface potential: red for negative, to blue for
positive, and white for neutral. The main chain of the C-terminal residues
is colored cyan; side chains are colored green, except for 1173, which is
colored purple for emphasis. The stretch of coiled-coil between residues 33
and 55 is shown; residues 168–178 of the interacting C-terminii are
depicted. A deep hydrophobic pocket, abutted against the N-cap, is created
within the grooves of the coiled-coil by T41 and F45 of different mono-
mers. The side chain of I173 from the same monomer as T41 fits into the
pocket and hydrogen bonds with Q42 of another monomer. The figure was
created with the program GRASP (Nicholls et al., 1991).
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subtype of HA to undergo conformational changes (Mark-
ovic et al., 2001) and therefore the difference between the
strains is possibly due to a greater number of activated
copies of the H3 subtype than the H2 subtype. Replacing the
TMD with a GPI anchor, or mutating the TMD, or reducing
contact between the N-cap and I173 arrests the fusion pro-
cess at hemifusion, and all should reduce cooperative ac-
tions between the TMDs and fusion peptides. The fact that
quite different means lead to the same result further sup-
ports our central hypothesis that the approach of TMDs and




HA2 mutants were generated by a rapid PCR scheme
utilizing Vent polymerase (New England Biolabs, Inc.)
which involves amplification of the complete plasmid (By-
rappa et al., 1995). The PCR was limited to 12 cycles to
minimize the chance of a mistake. For mutants A35E,
A35E-A36T, and D37V (in the N-cap region) and 1173E,
1173E-L178Q, V176E, and L178Q (in the C-terminal re-
gion), the mutations were made in pSMHAX:31, kindly
provided by Dr. Judith White. The StuI/XhoI fragment con-
taining each N-cap mutation and the XhoI/XbaI fragment
containing each C-terminal mutation were sequenced using
the Big Dye Terminator Cycle Sequencing Ready Reaction
Kit (Applied Biosystems, Foster City, CA) before being
excised and inserted into pCB6HAX:31, provided by Dr. J.
White. Mutants T41K, T41E, 1173Y, and 1173P were di-
rectly generated in pCB6HAX:31, using the same PCR
method, and the sequence was determined for 500 bp sur-
rounding the mutation.
Expression of wild-type and mutant HA
HEK293T human kidney cells were grown in DMEM
(GIBCO-BRL, Gaithersburg, MD) supplemented with 10%
Cosmic Calf Serum (Hyclone Laboratories, Logan, UT),
1% penicillin/streptomycin, 1% L-glutamine, and 100 g/ml
of geneticin. The wt HA and mutants were transiently ex-
pressed using a standard calcium phosphate transfection
method with chloroquine treatment (Luthman and Magnus-
son, 1983). Unless otherwise indicated, cells were trans-
fected with 6 g of HA-bearing plasmid per 6-cm dish.
Because T41K, T41E, and  173–178 mutants were poorly
expressed, here a greater amount of cDNA (24 g) was used
per dish. Cells were used for fusion experiments about 42 h
posttransfection. When expression levels had to be further
increased, 10 or 25 mM sodium butyrate was added the
night before cells were used for experiments (Danieli et al.,
1996). Cell surface expression was checked by cell-ELISA
(enzyme-linked immunosorbent assay) and FACS, using a
primary antibody directed against antigenic Site A (HA1
residues 105–139) (White and Wilson, 1987), provided by
Dr. J. White. Point mutants are denoted by standard con-
vention (e.g., I173P). I173-6A signifies a mutant in which
all residues from 173 to 178 were mutated to alanine;
I173-3A denotes a mutant in which residues 173–175 were
mutated to alanine; 173–178 signifies a mutant in which
the segment 173–178 was deleted.
Cell surface biotinylation, immunoprecipitation, and
Western blotting
Biotinylation of cell surface proteins was performed ac-
cording to published procedures (Qiao et al., 1999). Explic-
itly, transfected cells on a dish were washed twice with PBS
and treated with 1 ml of 1 mg/ml biotin for 45 min at 4°C.
Biotin was quenched by 0.05 mM glycine. To cleave HA0,
cells were treated with 10 g/ml TPCK-treated trypsin
(Sigma Chemical Co., St. Louis, MO) in PBS for 10 min at
room temperature (Qiao et al., 1998). The reaction was
stopped by adding an excess of DMEM containing 10%
fetal serum for 1 min at RT. Cells were then washed with
PBS, lysed in a cell lysis buffer containing 1% NP-40 and
a cocktail of protease inhibitors (Delos et al., 2000), and
incubated with 1 g/ml of Site A antibody (White and
Wilson, 1987) for 1 h at 4°C with rotation in order to
immunoprecipitate HA. Protein A–agarose beads (Pierce
Biotechnology, Rockford, IL) were added to and incubated
with the lysate for 1 h at 4°C with rotation. The protein A
beads were centrifuged at 14,000 rpm for 1 min and sequen-
tially washed with 12.5 mM potassium phosphate, pH 7.4,
0.6 M NaCl, 0.1% SDS, 0.05% NP-40, 0.3 M NaCl, 10 mM
Tris, pH 8.3, 12.5 mM potassium phosphate, pH 7.4, 0.3 M
NaCl, and finally 20 mM Tris, pH 8.3 (Kemble et al., 1993).
Immune complexes were resuspended in an SDS gel
loading buffer (containing 0.14 M -mercaptoethanol when
reducing conditions were required), boiled for 5 min, and
separated by 10% SDS–PAGE. Protein was transferred to a
nitrocellulose membrane that was then blocked with super-
blotto (0.5% Tween 20, 10% glycerol, 3% BSA wt/vol, 18%
glucose, and 1% dry mild in PBS) and probed with strepta-
vidin–HRP (horseradish peroxidase) as described previ-
ously (Qiao et al., 1998).
Monitoring HA conformational changes
Low-pH-induced conformational changes of HA were
assayed by cell-ELISA. Transfected cells were treated with
trypsin to cleave HA0, incubated in fusion buffer (20 mM
succinic acid, 100 mM NaCl, 1.5 mM KCl, 2.5 mM MgCl2,
2.5 mM CaCl2) at different pH values at 37°C for 15 min,
washed with PBS, and incubated with rabbit CHA-1 anti-
body (an antibody directed against HA1 98–106 which is
completely inaccessible in the native, neutral-pH form)
(White and Wilson, 1987) for 1 h at 4°C. Cells were then
washed with PBS, fixed with 2% paraformaldehyde for 15
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min at 4°C, and incubated with a secondary antirabbit an-
tibody conjugated with HRP for 1 h at 4°C. About 105 of
these fixed cells were allowed to attach, for 30 min at 4°C,
to wells of a 96-well plate coated with polylysine. The
solution was removed and 100 l of a substrate solution (1
mg of o-phenylendiamine, 0.1 M sodium citrate, pH 4.5,
and 1.5% H2O2) was added and incubated for 30–40 min at
RT. (The wells had been blocked by 100 l of 5% fetal
bovine serum in PBS for 15 min at 4°C to avoid nonspecific
attachment of substrate.) The ELISA plate was read at 450
nm.
Fusion between HA-expressing cells and RBCs
Fusion experiments between HA-expressing cells and
freshly collected human RBCs, colabeled with the mem-
brane probe octadecylrhodamine B chloride (R18) and the
aqueous dye carboxyfluorescein (CF) (both from Molecular
Probes, Inc. Eugene, OR), were performed essentially as
previously described (Melikyan et al., 1997, 2000a). In
essence, labeled RBCs were bound to HA-expressing cells,
fusion was triggered by acidifying to pH 5.0 for 2 min at
37°C, and dye spread was measured 10–15 min after re-
neutralization. The number of HA-expressing cells that
were stained with either membrane or aqueous dye was
normalized by the total number of cells with bound RBCs.
In electrical measurements, the formation of fusion pores
between HA-expressing cells and RBCs was monitored in
the whole-cell patch-clamp configuration as described pre-
viously (Melikyan et al., 1999). The internal pipette solution
was 155Cs glutamate, 5 mM MgCl2, 5 mM BAPTA, 10 mM
HEPES, pH 7.25. RBCs were labeled as in dye transfer
experiments to match their conditions. Fusion was triggered
by locally ejecting an acidic solution onto the HA cell–RBC
pair from another pipette of the same composition as the
bathing solution (135 mM N-methyl-glucamine aspartate, 5
mM MgCl2, 2 mM HEPES, pH 7.2) except that this pipette
solution was buffered to pH 5.0 with 20 mM Cs succinate.
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